Abstract |
Data from two short-term double-masked studies using 24 and 16 subjects suggest that topically applied levobunolol safely and effectively treats open-angle glaucoma and ocular hypertension. The onset of effect of a single drop of 0.5% levobunolol occurred within the first hour, producing a maximal hypotensive effect of more than 8 mm Hg after two hours. An intraocular pressure deceased of greater than or equal to 2 mm Hg was still observed after 24 hours for both concentrations of levobunolol tested (0.5% and 1%). Intraocular pressure decreases of more than 9 mm Hg persisted during a one-month trial in which patients were treated twice daily, confirming the results obtained in the 24-hour study. Systemic effects of both timolol (0.5%) and levobunolol (0.5% and 1%) included a consensual intraocular pressure-decreasing effect in the untreated eye and clinically significant reductions in heart rate. Diastolic blood pressure was decreased at two and four hours after administration of 0.5% levobunolol.
|
Authors | E Duzman, M Ober, A Scharrer, I H Leopold |
Journal | American journal of ophthalmology
(Am J Ophthalmol)
Vol. 94
Issue 3
Pg. 318-27
(Sep 1982)
ISSN: 0002-9394 [Print] United States |
PMID | 6751091
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Propanolamines
- Timolol
- Levobunolol
|
Topics |
- Administration, Topical
- Aged
- Blood Pressure
(drug effects)
- Clinical Trials as Topic
- Double-Blind Method
- Female
- Glaucoma
(drug therapy)
- Glaucoma, Open-Angle
(drug therapy)
- Humans
- Intraocular Pressure
(drug effects)
- Levobunolol
(administration & dosage)
- Male
- Propanolamines
(administration & dosage)
- Time Factors
- Timolol
(administration & dosage)
|